share_log

Why Is Elevance Health Stock Trading Lower On Thursday?

Why Is Elevance Health Stock Trading Lower On Thursday?

爲什麼Elevance Health股票週四下跌?
Benzinga ·  10/18 02:11

Elevance Health Inc. (NYSE:ELV) reported on Thursday third-quarter revenues of $44.7 billion, up 5.3% year-over-year, beating the consensus of $43.33 billion.

Evolent Health Inc. (NYSE:ELV)週四報告第三季度營業收入447億美元,同比增長5.3%,超過433.3億的共識。

The increase was driven by higher premium yields in the Health Benefits segment and growth in CarelonRx product revenue, partially offset by membership attrition in the Medicaid business.

提升主要由於醫療福利部門的高保費收益和CarelonRx產品營業收入增長所推動,部分抵消了Medicaid業務中的會員減少。

The benefit expense ratio was 89.5%, an increase of 270 basis points, driven primarily by the timing mismatch between Medicaid rates and the higher acuity of members.

福利支出比率爲89.5%,較去年增加270個點子,主要受Medicaid費率與成員更高嚴重性之間的時間錯配驅動。

The company forecasts an adjusted EPS of $33.00, down from the prior guidance of at least $37.20 and the consensus of $37.26.

公司預測調整後的每股收益爲33.00美元,低於之前至少37.20美元的指引和37.26美元的共識。

Evolent Health, Inc (NYSE:EVH) stock is trading lower in reaction to Elevance Health's mixed earnings and softer guidance.

Evolent Health, Inc (NYSE:EVH)股票在對Elevance Health的不確定盈利和較軟的指引反應下下跌。

Large managed care organizations (MCOs) seem to be facing pressure regarding Medicaid utilization, while outdated data often determine the premiums they receive from states, William Blair noted.

大型託管保健組織(MCOs)似乎面臨着關於Medicaid利用率的壓力,同時過時數據往往決定了它們從州政府獲得的保費,William Blair指出。

This situation created a disparity between payments and trends in medical expenses following the completion of the redeterminations process. However, this issue is anticipated to be temporary as MCOs collaborate with state partners to recalibrate their pricing.

這種情況導致了在重新確定流程完成後,支付金額和醫療費用趨勢之間存在不一致。然而,預計這個問題是暫時的,因爲MCOs正在與州夥伴合作重新調整定價。

"Last, we believe Evolent's services remain a compelling value proposition given continued cost pressures facing health plans on Medicare Advantage and Medicaid lines, presenting a compelling growth setup for coming years," William Blair analyst wrote.

「最後,我們認爲Evolent的服務仍然是一個引人注目的價值主張,鑑於醫療保險優勢和Medicaid業務面臨持續的成本壓力,爲未來幾年提供了引人注目的增長設置,」William Blair分析師寫道。

The analyst indicated Evolent's struggles were due to investors anticipating that rising medical costs would impact its at-risk performance suite.

分析師表示,Evolent的困境是由於投資者預期不斷增長的醫療成本將影響其風險表現套件。

ELV, EVH Price Actions: Elevance Health stock is down 12.12% at $436.64; Evolent Health stock is down 5.54% at $25.05 at publication Thursday.

ELV,EVH股價走勢:Elevance Health股價下跌12.12%,報436.64美元;Evolent Health股價下跌5.54%,報25.05美元,發佈時間爲週四。

  • Why Is GameSquare Stock Gaining Today?
  • 爲什麼GameSquare股票今天上漲?

Photo: Unsplash

照片:Unsplash

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論